Treatment devices and methods

• US 9,681,909 B2
• Filed: 06/23/2009
• Issued: 06/20/2017
• Est. Priority Date: 06/23/2008
• Status: Active Grant

• Current Assignee: AngioDynamics, Inc.
• Original Assignee: AngioDynamics, Inc.
• Inventors: Blau, David A., Pearson, Robert M., Bhargav, Shaily, Lovewell, James G.
• Primary Examiner(s): Peffley, Michael
• Assistant Examiner(s): VAHDAT, KHADIJEH A
• Application Number:
  US12/489,817
• Publication Number:
  US 20090318905A1
• Time in Patent Office: 2,919 Days
• Field of Search: 606 32- 34, 606 41
• CPC Class Codes: A61B 18/12 by passing a current through the tissue to be heated, e.g. high-frequency current
• CPC Class Codes: A61B 18/1206 Generators therefor
• CPC Class Codes: A61B 18/14 Probes or electrodes therefor
• CPC Class Codes: A61B 2018/1273 including multiple generators in one device
• CPC Class Codes: A61B 2018/1467 using more than two electrodes on a single probe
• CPC Class Codes: A61B 2018/147 Electrodes transferring energy by capacitive coupling, i.e. with a dielectricum between electrode and target tissue

Abstract

A tissue treatment selection device that has at least one treatment delivery member, a delivery setting circuit that is coupled to the treatment delivery member that is adapted to be deployed into tissue to deliver therapeutic energy to a target tissue zone, and the processing circuit is operable to set treatment parameters in the delivery setting circuit. The processing circuit is operable to transmit a test signal through the deployed treatment delivery member and to determine deployment status. The treatment selection device has a processing circuit adapted to send a message to a display device that indicates that the deployed treatment delivery member has been determined to be compensable and contains a suggested change in the treatment parameters. Also presented herein is a method of treating a tissue of a patient using the treatment delivery device.

Claims

1. A treatment selection device comprising:

a treatment delivery device comprising at least a first treatment delivery member and a second treatment delivery member, each to be deployed into tissue to deliver irreversible electroporation (IRE) energy to a target tissue zone;

a processing circuit programmed to;

set a plurality of treatment parameters;

transmit a test signal through at least one of the deployed first treatment delivery member and the deployed second treatment delivery member; and

determine that the deployed first treatment delivery member or the deployed second treatment delivery member has been mis-deployed prior to treatment based upon a depth of the deployed first treatment delivery member or the deployed second treatment delivery member, and a distance between the deployed first treatment delivery member and the deployed second treatment delivery member; and

determine a change to at least one of the plurality of treatment parameters to compensate for the mis-deployment of the first treatment delivery member or the second treatment delivery member without withdrawing the deployed first treatment delivery member or deployed second treatment delivery member from the target tissue zone.

2. The treatment selection device of claim 1,

wherein the processing circuit is programmed to automatically change the at least one of the plurality of treatment parameters to compensate for the mis-deployment of the first treatment delivery member or the second treatment delivery member.

3. The treatment selection device of claim 1, wherein the processing circuit is programmed to send a message to a display device that indicates that the deployed first treatment delivery member or the deployed second treatment delivery member has been mis-deployed prior to treatment.

4. The treatment selection device of claim 1, wherein the processing circuit is programmed to send a message to a display device that indicates the determined change to at least one of the plurality of treatment parameters to compensate for the mis-deployment of the first treatment delivery member or the second treatment delivery member.

5. The treatment selection device of claim 1, wherein the processing circuit is further programmed to determine the distance between the deployed first treatment delivery member and the deployed second treatment delivery member based upon an impedence measurement from the test signal.

6. A method of treating a tissue of a patient using a treatment delivery device having at least a first treatment delivery member and a second treatment delivery member, each to be deployed into the tissue to deliver irreversible electroporation (IRE), the method comprising:

piercing the tissue with the first treatment delivery member and the second treatment delivery member so as to deploy the first treatment delivery member and the second treatment delivery member;

applying at least one test signal through at least one of the deployed first treatment delivery member and the deployed second treatment delivery member;

determining, based on the applied test signal, that the deployed first treatment delivery member or the deployed second treatment delivery member has been mis-deployed prior to treatment based upon a depth of the deployed first treatment delivery member or the deployed second treatment delivery member, and a distance between the deployed first treatment delivery member and the deployed second treatment delivery member; and

determining a change to at least one of a plurality of treatment parameters to compensate for the mis-deployment of the first treatment delivery member or the second treatment delivery member without withdrawing the deployed first treatment delivery member or the deployed second treatment delivery member from the tissue.

7. The method of claim 6, further comprising:

automatically changing the at least one of the plurality of treatment parameters while the treatment delivery member is deployed in the tissue.

8. The method of claim 7, wherein the step of automatically changing includes changing one or more of a treatment energy voltage, treatment energy duration, electrical polarity, output power level, combination of treatment delivery members, and number of treatment energy pulses.

9. The method of claim 6, further comprising sending a message to a display device that indicates that the deployed first treatment delivery member or the deployed second treatment delivery member has been mis-deployed prior to treatment.

10. The method of claim 9, further comprising sending a message to a display device that contains the determined change to at least one of the plurality of treatment parameters to compensate for the mis-deployment of the first treatment delivery member or the second treatment delivery member.

11. The method of claim 6, wherein

wherein the step of piercing the tissue includes deploying the first treatment delivery member and the second treatment delivery member from within the treatment delivery device.

12. The method of claim 6, wherein determining the distance between the deployed first treatment delivery member and the deployed second treatment delivery member is based upon an impedence measurement from the test signal.

13. A treatment selection device comprising:

a treatment delivery device comprising a longitudinal shaft and at least two treatment delivery members to be deployed into tissue to delivery irreversible electroporation (IRE) energy to a target tissue zone;

wherein the at least two treatment delivery members are deployed radially outwardly from the longitudinal shaft of the treatment delivery device into the target tissue zone; and

a processing circuit programmed to;

set a plurality treatment parameters;

transmit at least one test signal through the at least two deployed treatment delivery members; and

determine that at least one of the least two deployed treatment delivery members has been mis-deployed prior to treatment based upon a depth of the least two treatment delivery members and a distance between the at least two treatment delivery members; and

determine a change to at least one of the plurality of treatment parameters to compensate for the mis-deployment of at least one of the least two deployed treatment delivery members without withdrawing the at least two treatment delivery members from the target tissue zone.

14. The treatment selection device of claim 13, wherein:

the processing circuit is further programmed to determine the distance between the at least two treatment delivery members based upon an impedence measurement from the test signal.